AR126290A1 - Método para producir derivado de benzoxazol que tiene anillo bicíclico de piperazina o sal de este, y método para producir materia prima de este - Google Patents
Método para producir derivado de benzoxazol que tiene anillo bicíclico de piperazina o sal de este, y método para producir materia prima de esteInfo
- Publication number
- AR126290A1 AR126290A1 ARP220101722A ARP220101722A AR126290A1 AR 126290 A1 AR126290 A1 AR 126290A1 AR P220101722 A ARP220101722 A AR P220101722A AR P220101722 A ARP220101722 A AR P220101722A AR 126290 A1 AR126290 A1 AR 126290A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- salt
- producing
- group
- represented
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 10
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title 2
- 238000004519 manufacturing process Methods 0.000 title 2
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical class C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 title 1
- 239000002994 raw material Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 9
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 2
- 125000005002 aryl methyl group Chemical group 0.000 abstract 1
- 125000006165 cyclic alkyl group Chemical group 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
- 125000000437 thiazol-2-yl group Chemical group [H]C1=C([H])N=C(*)S1 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Health & Medical Sciences (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021108230 | 2021-06-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR126290A1 true AR126290A1 (es) | 2023-10-04 |
Family
ID=84691891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP220101722A AR126290A1 (es) | 2021-06-30 | 2022-06-30 | Método para producir derivado de benzoxazol que tiene anillo bicíclico de piperazina o sal de este, y método para producir materia prima de este |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240309010A1 (https=) |
| EP (1) | EP4365174A4 (https=) |
| JP (2) | JP7476431B2 (https=) |
| KR (1) | KR20240027603A (https=) |
| CN (2) | CN121873082A (https=) |
| AR (1) | AR126290A1 (https=) |
| AU (1) | AU2022300611A1 (https=) |
| BR (1) | BR112023025934A2 (https=) |
| CA (1) | CA3223354A1 (https=) |
| IL (1) | IL309736A (https=) |
| MX (1) | MX2023014123A (https=) |
| WO (1) | WO2023277120A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9890142B2 (en) * | 2013-07-10 | 2018-02-13 | Meiji Seika Pharma Co., Ltd. | PDE4 inhibitor |
| MX389276B (es) * | 2016-12-26 | 2025-03-20 | Meiji Seika Pharma Co Ltd | Compuesto novedoso y sal de este aceptable desde el punto de vista farmacologico. |
| KR102931303B1 (ko) * | 2018-06-27 | 2026-02-25 | 메이지 세이카 파루마 가부시키가이샤 | 염증성 질환, 자가면역 질환, 섬유화 질환 및 암 질환의 치료제 |
| JP2021155336A (ja) * | 2018-06-27 | 2021-10-07 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 新規ｐｄｅ４阻害剤 |
-
2022
- 2022-06-30 MX MX2023014123A patent/MX2023014123A/es unknown
- 2022-06-30 JP JP2023532045A patent/JP7476431B2/ja active Active
- 2022-06-30 CN CN202610020318.9A patent/CN121873082A/zh active Pending
- 2022-06-30 IL IL309736A patent/IL309736A/en unknown
- 2022-06-30 CA CA3223354A patent/CA3223354A1/en active Pending
- 2022-06-30 KR KR1020237043708A patent/KR20240027603A/ko active Pending
- 2022-06-30 WO PCT/JP2022/026168 patent/WO2023277120A1/ja not_active Ceased
- 2022-06-30 EP EP22833266.4A patent/EP4365174A4/en active Pending
- 2022-06-30 BR BR112023025934A patent/BR112023025934A2/pt unknown
- 2022-06-30 AU AU2022300611A patent/AU2022300611A1/en active Pending
- 2022-06-30 AR ARP220101722A patent/AR126290A1/es unknown
- 2022-06-30 US US18/575,158 patent/US20240309010A1/en active Pending
- 2022-06-30 CN CN202280035356.1A patent/CN117295744A/zh active Pending
-
2024
- 2024-04-17 JP JP2024067062A patent/JP7839217B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP7839217B2 (ja) | 2026-04-01 |
| CN117295744A (zh) | 2023-12-26 |
| EP4365174A4 (en) | 2025-07-02 |
| US20240309010A1 (en) | 2024-09-19 |
| KR20240027603A (ko) | 2024-03-04 |
| MX2023014123A (es) | 2023-12-12 |
| BR112023025934A2 (pt) | 2024-02-27 |
| JP7476431B2 (ja) | 2024-04-30 |
| EP4365174A1 (en) | 2024-05-08 |
| AU2022300611A1 (en) | 2024-01-25 |
| WO2023277120A1 (ja) | 2023-01-05 |
| CN121873082A (zh) | 2026-04-17 |
| TW202311242A (zh) | 2023-03-16 |
| JP2024096941A (ja) | 2024-07-17 |
| JPWO2023277120A1 (https=) | 2023-01-05 |
| IL309736A (en) | 2024-02-01 |
| CA3223354A1 (en) | 2023-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123186T1 (el) | Μακροκυκλικοι mcl1 αναστολεις για τη θεραπευτικη αντιμετωπιση του καρκινου | |
| BR112019007039A2 (pt) | pirrolidinas substituídas e seus métodos de uso no tratamento de fibrose cística | |
| ECSP066647A (es) | Derivados de triazol como antagonistas de vasopresina | |
| PE20170323A1 (es) | Derivados de indano e indolina y el uso de los mismos como activadores de la guanilato ciclasa soluble | |
| AR074435A1 (es) | Derivados de 1,3-benzotiazol, medicamentos que los contienen y uso de los mismos en el tratamiento del cancer. | |
| CO5031253A1 (es) | Antagonistas receptores y5 de neuropeptidos composiciones farmaceuticas que las contienen | |
| CL2021000481A1 (es) | Inhibidores de sarcómeros cardíacos. | |
| MX2023010377A (es) | Derivado policiclico de carbamoilpiridona. | |
| CL2023001367A1 (es) | Inhibidores de btk | |
| AR108777A1 (es) | Compuestos antibacterianos | |
| AR054482A1 (es) | Derivados de azetidinona para el tratamiento de hiperlipidemias | |
| PE20211780A1 (es) | Compuestos de pirimidinodiona biciclicos sustituidos con tetrahidropirano (thp) | |
| MX385276B (es) | Tratamiento para la enfermedad de parkinson | |
| MX2019007684A (es) | Compuesto novedoso y sal de este aceptable desde el punto de vista farmacologico. | |
| AR039111A1 (es) | Tiopirimidinas e isotiazolpirimidinas inhibidoras de quinasas | |
| AR126290A1 (es) | Método para producir derivado de benzoxazol que tiene anillo bicíclico de piperazina o sal de este, y método para producir materia prima de este | |
| ES340820A1 (es) | Procedimiento para la preparacion de derivados de la tiaze-pina. | |
| AR043537A1 (es) | Derivados azabiciclicos de piridiloximetilo y bencisoxazol | |
| AR053131A1 (es) | Tetraciclinas 9-sustituidas | |
| AR048834A1 (es) | Compuestos derivados de piperidina o tropano; metodos para su preparacion; composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades mediadas por quimioquinas (ccr5) | |
| CO2021008253A2 (es) | Derivado de cicloalcano-1,3-diamina | |
| MX390507B (es) | Compuestos de amida y su uso. | |
| PE20040765A1 (es) | 4-amino piperidinas n,n-disustituidas como inhibidores de la captacion de monoamina | |
| ES2141763T3 (es) | Fenilcarbonatos y fenilureas sustituidos, su preparacion y su uso como antagonistas de 5-ht4. | |
| PE20181003A1 (es) | Compuestos terapeuticos y sus metodos de uso |